Groupe Bruxelles Lambert SA
Groupe Bruxelles Lambert SA Fundamental Analysis
Groupe Bruxelles Lambert SA (GBLBF) shows weak financial fundamentals with a PE ratio of -22.30, profit margin of -3.21%, and ROE of -1.72%. The company generates $13.3B in annual revenue with weak year-over-year growth of -4.65%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 14.8/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze GBLBF's fundamental strength across five key dimensions:
Efficiency Score
WeakGBLBF struggles to generate sufficient returns from assets.
Valuation Score
ExcellentGBLBF trades at attractive valuation levels.
Growth Score
ModerateGBLBF shows steady but slowing expansion.
Financial Health Score
ExcellentGBLBF maintains a strong and stable balance sheet.
Profitability Score
WeakGBLBF struggles to sustain strong margins.
Key Financial Metrics
Is GBLBF Expensive or Cheap?
P/E Ratio
GBLBF trades at -22.30 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, GBLBF's PEG of -0.26 indicates potential undervaluation.
Price to Book
The market values Groupe Bruxelles Lambert SA at 0.44 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 12.51 times EBITDA. This signals the market has high growth expectations.
How Well Does GBLBF Make Money?
Net Profit Margin
For every $100 in sales, Groupe Bruxelles Lambert SA keeps $-3.21 as profit after all expenses.
Operating Margin
Core operations generate 6.71 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $-1.72 in profit for every $100 of shareholder equity.
ROA
Groupe Bruxelles Lambert SA generates $-0.95 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Groupe Bruxelles Lambert SA generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.
Free Cash Flow
Groupe Bruxelles Lambert SA generates weak or negative free cash flow of $0.00, restricting financial flexibility.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
GBLBF converts 0.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
-22.30
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-0.26
vs 25 benchmark
P/B Ratio
Price to book value ratio
0.44
vs 25 benchmark
P/S Ratio
Price to sales ratio
1.25
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.60
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.91
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
-0.02
vs 25 benchmark
ROA
Return on assets percentage
-0.01
vs 25 benchmark
ROCE
Return on capital employed
0.02
vs 25 benchmark
How GBLBF Stacks Against Its Sector Peers
| Metric | GBLBF Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | -22.30 | 18.80 | Better (Cheaper) |
| ROE | -1.72% | 817.00% | Weak |
| Net Margin | -3.21% | -55.00% (disorted) | Weak |
| Debt/Equity | 0.60 | 1.03 | Strong (Low Leverage) |
| Current Ratio | 1.91 | 661.52 | Neutral |
| ROA | -0.95% | -23757.00% (disorted) | Weak |
GBLBF outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Groupe Bruxelles Lambert SA's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
37.42%
Industry Style: Value, Dividend, Cyclical
High GrowthEPS CAGR
-77.91%
Industry Style: Value, Dividend, Cyclical
DecliningFCF CAGR
46.98%
Industry Style: Value, Dividend, Cyclical
High Growth